UBS Group’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $36K | Buy |
|
|||||
|
2017
Q4 | $107K | Sell |
|
|||||
|
2017
Q3 | $117K | Buy |
|
|||||
|
2017
Q2 | $95K | Buy |
|
|||||
|
2017
Q1 | $160K | Buy |
|
|||||
|
2016
Q4 | $222K | Buy |
|
|||||
|
2016
Q3 | $661K | Buy |
|
|||||
|
2016
Q2 | $296K | Buy |
|
|||||
|
2016
Q1 | $279K | Buy |
|
|||||
|
2015
Q4 | $169K | Buy |
|
|||||
|
2015
Q3 | $116K | Buy |
|
|||||
|
2015
Q2 | $47K | Buy |
|
|||||
|
2015
Q1 | $4K | Sell |
|
|||||
|
2014
Q4 | $5K | Buy |
|